Patients with cardiac amyloidosis were older, were more frequently male, and had higher prevalence of atrial fibrillation and higher levels of NT‐proBNP (median NT‐proBNP 3446 vs. 1547 pg/ml for patients with vs. without cardiac amyloidosis). The gene discussed is NPPB; the disease is atrial fibrillation.